Retractable Technologies (NYSE:RVP) Coverage Initiated at StockNews.com

Investment analysts at StockNews.com started coverage on shares of Retractable Technologies (NYSE:RVP) in a note issued to investors on Monday. The firm set a “hold” rating on the stock.

Retractable Technologies Stock Performance

NYSE:RVP opened at $0.82 on Monday. The company has a debt-to-equity ratio of 0.01, a quick ratio of 5.92 and a current ratio of 8.57. The stock has a 50-day simple moving average of $0.66 and a two-hundred day simple moving average of $0.85. The firm has a market capitalization of $24.40 million, a PE ratio of -1.51 and a beta of 1.94. Retractable Technologies has a 52-week low of $0.56 and a 52-week high of $1.34.

Institutional Trading of Retractable Technologies

An institutional investor recently bought a new position in Retractable Technologies stock. PFG Investments LLC purchased a new position in Retractable Technologies, Inc. (NYSE:RVP) during the third quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned approximately 0.12% of Retractable Technologies at the end of the most recent quarter. 7.58% of the stock is currently owned by institutional investors.

Retractable Technologies Company Profile

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.